EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT

被引：1

作者：

Nathan, Steven ^{[1
]}

Bradley, Sarah ^{[1
]}

Costabel, Ulrich ^{[1
]}

Albera, Carlo ^{[1
]}

Behr, Juergen ^{[1
]}

Wuyts, Wim ^{[1
]}

Kirchgaessler, Klaus-Uwe ^{[1
]}

Stauffer, John ^{[1
]}

Morgenthien, Elizabeth ^{[1
]}

Yang, Ming ^{[1
]}

Limb, Susan ^{[1
]}

Noble, Paul ^{[1
]}

机构：

[1] Inova Fairfax Hosp, Annandale, VA USA

来源：

CHEST | 2018年 / 154卷 / 04期

关键词：

D O I：

10.1016/j.chest.2018.08.394

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：432A / 433A

页数：2

共 50 条

[41] IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in Europe
Annette Duck
Lucy Pigram
Peter Errhalt
Deeba Ahmed
Nazia Chaudhuri
Advances in Therapy, 2015, 32 : 87 - 107
[42] Effect of graded exercise rehabilitation based on pulmonary function classification on dyspnea, pulmonary function, and exercise capacity in elderly lung cancer patients
Zhang, Ruiping
Jiang, Xueting
Liu, Weidi
Zhang, Ning
Shang, Jiao
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (11): : 6552 - 6563
[43] Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, Paul W.
Albera, Carlo
Bradford, Williamson Z.
Costabel, Ulrich
Glassberg, Marilyn K.
Kardatzke, David
King, Talmadge E., Jr.
Lancaster, Lisa
Sahn, Steven A.
Szwarcberg, Javier
Valeyre, Dominique
du Bois, Roland M.
LANCET, 2011, 377 (9779): : 1760 - 1769
[44] Impact Of Statins On Lung Function Decline In Idiopathic Pulmonary Fibrosis (ipf)
Kreuter, M.
Bonella, F.
Maher, T. M.
Costabel, U.
Spagnolo, P.
Weycker, D.
Kirchgassler, K. -U.
Kolb, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[45] Effect Of Continued Treatment With Pirfenidone Following A ≥10% Relative Decline In Percent Predicted Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis (ipf)
Nathan, S. D.
Albera, C.
Costabel, U.
Glaspole, I.
Glassberg, M.
Lancaster, L.
Lederer, D. J.
Pereira, C. A.
Swigris, J.
Day, B. -M.
Chou, W.
Wells, A. U.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[46] Effect Of Continued Treatment With Pirfenidone Following A Clinically Meaningful Decline In Percent Predicted Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis (ipf)
Nathan, S. D.
Albera, C.
Bradford, W. Z.
Costabel, U.
Du Bois, R. M.
Fagan, E. A.
Glaspole, I.
Glassberg, M. K.
King, T. E.
Lancaster, L.
Lederer, D. J.
Lin, Z.
Pereira, C. A.
Swigris, J. J.
Valeyre, D.
Noble, P. W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[47] Effect Of Baseline Gap Index Stage On Decline In Lung Function With Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf)
Ryerson, C. J.
Kolb, M.
Richeldi, L.
Lee, J.
Kimura, T.
Stowasser, S.
Poletti, V.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[48] Efficacy of Pirfenidone in Patients with Advanced-stage Idiopathic Pulmonary Fibrosis
Sakamoto, Susumu
Itoh, Takafumi
Muramatsu, Yoko
Satoh, Keita
Ishida, Fumiaki
Sugino, Keishi
Isobe, Kazutoshi
Homma, Sakae
INTERNAL MEDICINE, 2013, 52 (22) : 2495 - 2501
[49] EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A CLINICALLY MEANINGFUL DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
Noble, P. W.
Albera, C.
Bradford, W. Z.
Costabel, U.
Glaspole, I.
Glassberg, M. K.
Lancaster, L.
Lederer, D. J.
Lin, Z.
Pereira, C. A.
Swigris, J. J.
Valeyre, D.
Nathan, S. D.
THORAX, 2015, 70 : A62 - A63
[50] Effects of low dose pirfenidone on lung function for patients with idiopathic pulmonary fibrosis in real practice
Moon, K. M.
Jung, B.
Lee, J. G.
Kim, M. P.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60

← 1 2 3 4 5 →